These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Fonseca SB; Pereira MP; Kelley SO Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995 [TBL] [Abstract][Full Text] [Related]
6. Cell-penetrating peptides are excluded from the mitochondrial matrix. Ross MF; Murphy MP Biochem Soc Trans; 2004 Dec; 32(Pt 6):1072-4. PubMed ID: 15506968 [TBL] [Abstract][Full Text] [Related]
7. Cell membranes open "doors" for cationic nanoparticles/biomolecules: insights into uptake kinetics. Lin J; Alexander-Katz A ACS Nano; 2013 Dec; 7(12):10799-808. PubMed ID: 24251827 [TBL] [Abstract][Full Text] [Related]
8. Chemically modified cell-penetrating peptides for the delivery of nucleic acids. Mäe M; Andaloussi SE; Lehto T; Langel U Expert Opin Drug Deliv; 2009 Nov; 6(11):1195-205. PubMed ID: 19831582 [TBL] [Abstract][Full Text] [Related]
9. Distinct uptake routes of cell-penetrating peptide conjugates. Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426 [TBL] [Abstract][Full Text] [Related]
10. Endosome-disruptive peptides for improving cytosolic delivery of bioactive macromolecules. Nakase I; Kobayashi S; Futaki S Biopolymers; 2010; 94(6):763-70. PubMed ID: 20564044 [TBL] [Abstract][Full Text] [Related]
11. Endo-Porter: a novel reagent for safe, effective delivery of substances into cells. Summerton JE Ann N Y Acad Sci; 2005 Nov; 1058():62-75. PubMed ID: 16394126 [TBL] [Abstract][Full Text] [Related]
12. Intrinsically cell-permeable miniature proteins based on a minimal cationic PPII motif. Daniels DS; Schepartz A J Am Chem Soc; 2007 Nov; 129(47):14578-9. PubMed ID: 17983240 [TBL] [Abstract][Full Text] [Related]
13. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177 [TBL] [Abstract][Full Text] [Related]
14. Tuning the activity of mitochondria-penetrating peptides for delivery or disruption. Horton KL; Pereira MP; Stewart KM; Fonseca SB; Kelley SO Chembiochem; 2012 Feb; 13(3):476-85. PubMed ID: 22238158 [TBL] [Abstract][Full Text] [Related]
15. Cell penetrating agents based on a polyproline helix scaffold. Fillon YA; Anderson JP; Chmielewski J J Am Chem Soc; 2005 Aug; 127(33):11798-803. PubMed ID: 16104758 [TBL] [Abstract][Full Text] [Related]
16. Mitochondria-penetrating peptides: sequence effects and model cargo transport. Yousif LF; Stewart KM; Horton KL; Kelley SO Chembiochem; 2009 Aug; 10(12):2081-8. PubMed ID: 19670199 [TBL] [Abstract][Full Text] [Related]
17. Arginine-rich cell penetrating peptides: from endosomal uptake to nuclear delivery. Melikov K; Chernomordik LV Cell Mol Life Sci; 2005 Dec; 62(23):2739-49. PubMed ID: 16231085 [TBL] [Abstract][Full Text] [Related]
18. Gene delivery by cationic lipids: in and out of an endosome. Hoekstra D; Rejman J; Wasungu L; Shi F; Zuhorn I Biochem Soc Trans; 2007 Feb; 35(Pt 1):68-71. PubMed ID: 17233603 [TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Zorko M; Langel U Adv Drug Deliv Rev; 2005 Feb; 57(4):529-45. PubMed ID: 15722162 [TBL] [Abstract][Full Text] [Related]